Table 2.

Schedule of assessments

	MI hospitalization	Screening (2-months post-MI)	Baseline	Post-treatment	6-month Follow-up
Demographics	X*		X
Clinical lab results, vitals	X*
Medical history, medications	X*	X	X	X	X
Perceived stress (PSS)†	X*	X	X	X	X
Disease-specific health status (SAQ-7)			X	X	X
Quality of life (SF-12, PROMIS-10)			X	X	X
Depressive symptoms (PHQ-9)		X	X	X	X
Anxiety symptoms (HADS-A)			X	X	X
Sleep (actigraphy)			X	X	X
Mindfulness (FFMQ-SF)			X	X	X
Rumination (RRQ)			X	X	X
Perceived social support (ESSI)			X	X	X

^*Data collected as part of the HARP Clinical study.

^†The PSS-4 will be used at the MI hospitalization and 2-month screening visits; the PSS-10 will be used at the baseline and follow-up visits.